Ian Oldham

Ian Oldham has over 20 years of experience in the field of Regulatory Operations. Ian began their career in 1999 as a Regulatory Affairs Labeling Associate at DuPont Pharmaceuticals. In 2002, they moved to Endo Pharmaceuticals in the same role. In 2008, they were promoted to Manager, Regulatory Affairs Publishing at Alcon Laboratories, Inc. One year later, they joined AstraZeneca as a Regulatory Affairs Publishing Associate. In 2010, they moved to Teva Pharmaceuticals as a Senior Manager, Regulatory Submissions Management and Senior Specialist, Regulatory Submissions Management, where they were an essential contributor to first-pass agency submittals and provided training and support for Regulatory systems. In 2016, they became Director, Regulatory Operations at inVentiv Health Clinical, and then moved to Karyopharm Therapeutics Inc. in 2017 in the same role. In 2018, they were promoted to Associate Director Regulatory Operations at Upsher-Smith Laboratories, LLC. In 2019, they joined TherapeuticsMD as Senior Director, Regulatory Operations, and in 2022, they moved to Adlai Nortye Biopharma Co., Ltd in the same role.

Ian Oldham graduated from Wilmington University in 2007 with a Bachelor of Arts in Business Management.